Collegium Pharmaceutical Inc (COLL)
35.84
+0.36
(+1.01%)
USD |
NASDAQ |
Apr 25, 16:00
35.85
+0.01
(+0.03%)
After-Hours: 20:00
Collegium Pharmaceutical Gross Profit Margin (Quarterly): 63.19% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 63.19% |
| September 30, 2023 | 58.75% |
| June 30, 2023 | 54.47% |
| March 31, 2023 | 53.47% |
| December 31, 2022 | 38.41% |
| September 30, 2022 | 46.33% |
| June 30, 2022 | 42.38% |
| March 31, 2022 | 57.90% |
| December 31, 2021 | -4.87% |
| September 30, 2021 | 58.49% |
| June 30, 2021 | 60.57% |
| March 31, 2021 | 63.38% |
| December 31, 2020 | 58.07% |
| September 30, 2020 | 60.87% |
| June 30, 2020 | 61.96% |
| Date | Value |
|---|---|
| March 31, 2020 | 50.96% |
| December 31, 2019 | 33.85% |
| September 30, 2019 | 35.90% |
| June 30, 2019 | 35.16% |
| March 31, 2019 | 34.02% |
| December 31, 2018 | 59.52% |
| September 30, 2018 | 34.44% |
| June 30, 2018 | 35.89% |
| March 31, 2018 | 32.38% |
| December 31, 2017 | 89.86% |
| September 30, 2017 | 95.37% |
| June 30, 2017 | 83.79% |
| March 31, 2017 | 82.92% |
| December 31, 2016 | 85.88% |
| September 30, 2016 | 92.89% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-4.87%
Minimum
Dec 2021
63.38%
Maximum
Mar 2021
48.91%
Average
54.47%
Median
Jun 2023
Gross Profit Margin (Quarterly) Benchmarks
| Immunogen Inc (DELISTED) | 98.10% |
| Supernus Pharmaceuticals Inc | 88.06% |
| AnaptysBio Inc | -- |
| Recursion Pharmaceuticals Inc | 6.99% |
| Nuvalent Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 25.35% |
| Return on Assets | 4.06% |
| Return on Invested Capital | 5.25% |
| Profit Margin (Quarterly) | 21.33% |
| Operating Margin (Quarterly) | 41.20% |
| Return on Net Operating Assets | 5.53% |